Filter by

  • Publication Year
  • Availability
  • Attachment
  • Collection Type
    See More
  • General Material Designation
    See More
  • Location
    See More
  • Language
Found 5 from your keywords: subject="Capecitabine"
cover
Effect of Reduced-Dose Capecitabine Plus Cetuximab as Maintenance Therapy for…
Comment Share
Wang L

Fluorouracil-based chemotherapy combined with anti–epidermal growth factor receptor/vascular endothelial growth factor therapy is the standard first-line treatment for metastatic colorectal cancer followed by low-intensity maintenance therapy to balance the clinical efficacy and adverse effects (AEs). However, there have been concerns about the AEs of capecitabine plus cetuximab as a mainten…

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-
cover
Capecitabine in the routine first-line treatment of elderly patients with adv…
Comment Share
Stein A

The purpose of this observational study was to evaluate feasibility, efficacy results and toxicity observations of capecitabine in routine first line treatment of patients with metastatic colorectal cancer, with particular regard of elderly patients (>75 years of age

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-
cover
Capecitabine Versus Active Monitoring in Stable or Responding Metastatic Colo…
Comment Share
Adams RA

Despite extensive randomized evidence supporting the use of treatment breaks in metastatic colorectal cancer (mCRC), they are not universally offered to patients despite improvements in quality of life without detriment to overall survival (OS). FOCUS4-N was set up to explore the impact of oral maintenance therapy in patients who are responding to first-line therapy

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-
cover
Capecitabine for hormone receptor-positive versus hormone receptor-negative b…
Comment Share
Hoon SN

Retrospective analyses suggest that capecitabine may carry superior activity in hormone receptor-positive relative to hormone receptornegative metastatic breast cancer. This review examined the veracity of that finding and explored whether this diJerential activity extends to early breast cancer

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-
cover
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy
Comment Share
Masuda N

Patients who have residual invasive carcinoma after the receipt of neoadjuvant chemotherapy for human epidermal growth factor receptor 2 (HER2)–negative breast cancer have poor prognoses. The benefit of adjuvant chemotherapy in these patients remains unclear.

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-